Loading page…
Hyloris Pharmaceuticals SA 2024 Sustainability Report
Company: Hyloris Pharmaceuticals SA
Sector: Manufacturing
Country: Belgium
Year: 2024
Type: Sustainability Report
Pages: 15
The report describes Hyloris's 2024 sustainability approach across environmental, social, and governance topics. It highlights environmental risk assessments, a transition to hybrid and fully electric vehicles, and a workforce comprising 35 self-employed professionals and 14 employees. The report states that there were zero work-related accidents and emphasizes patient-health initiatives, including Maxigesic IV's approval in more than 50 countries.
Indicators available in this report: